The Use of the Chuang's Prognostic Scale to Predict the Survival of Metastatic Colorectal Cancer Patients Receiving Palliative Systemic Anticancer Therapy

BACKGROUND: With the increasing number of agents active against cancer, advanced cancer patients including metastatic colorectal cancer (mCRC) patients may continue receiving palliative systemic anticancer therapy (PSAT) near the end-of-life. Validated palliative prognostic models, such as the Chuan...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsirafy, Samy A, Zaki, Omar, Sakr, Amr Y, Farag, Dina E, El-Sherief, Wessam A, Mohammed, Abha A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973493/
https://www.ncbi.nlm.nih.gov/pubmed/27559261
http://dx.doi.org/10.4103/0973-1075.185043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973493/
https://www.ncbi.nlm.nih.gov/pubmed/27559261
http://dx.doi.org/10.4103/0973-1075.185043

Ejemplares similares